hotspot -WSS

hotspot

author：entertainment 2025-10-01 21:33:29 - browse：413

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Heart disease in astronauts blamed on cosmic radiation

WSS

Medicare slashes safety net hospital payments by nearly $1 billion

H.R. 3 is the wrong path to lower drug costs

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Congress extends some pandemic preparedness programs

Health insurers' Q3 question: how much care are people getting?

H.R. 3 is the wrong path to lower drug costs

Wikipedia

hotspot

focus

Drug repurposing or repositioning? The language matters

What we owe ALS patients — and why one company fell short

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Virginia high school admissions case could be legal follow

European officials brace for rough respiratory virus season

Drug repurposing or repositioning? The language matters

FDA scientists endorse Pfizer/BioNTech Covid

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Setback for rare diseases as Taysha Gene Therapies pulls back

focus

Biotech startup Celsius cuts 75% of staff ahead of first trial start

FDA approves Sage Therapeutics’ rapid

The a glaring gap in research on serious mental illness and primary care

The cancer stories no one wants to hear

With Roe v Wade overturned, abortion providers work to adapt

Health insurers' Q3 question: how much care are people getting?

leisure time

explore

explore

hotspot